LifeBridge Health

New Data-Driven Approach for Communities At Risk for Severe COVID-19 Outcomes

Newswise — Beginning this week, a statewide Taskforce on Vulnerable Populations for COVID-19 in Maryland began implementing a data-driven approach to identifying communities and individuals at highest risk for severe outcomes from COVID-19. They are using this data and mapping to guide the deployment of outreach and resources to vulnerable populations including homeless, elderly living in congregate dwellings and those with limited healthcare access.

The taskforce, led by Susan Mani, MD, LifeBridge Health’s Chief Population Health Officer, engaged a company called Socially Determined to leverage information from multiple data sources to generate a COVID-19 risk index for severe outcomes that was mapped on a county, city and neighborhood level throughout Maryland. (see attached examples of data and mapping – darker red areas had highest risk index).

 The risk score for communities and individuals and corresponding maps were shared with municipal health officials.  Those local health officials can take the data and mapping into account along with their local expertise to deploy their outreach, moving high risk groups into hotels for social distancing, testing, etc. 

Additionally, the Taskforce on Vulnerable Populations secured approval from Secretary of Health Robert R. Neall to create and deploy Testing and Manage in Place Teams comprised of EMS personnel and social workers/community health workers to institute measures designed to prevent negative COVID-19 outcomes to the most vulnerable communities. 

 As Testing and Manage in Place Teams are deployed, they are able to provide testing on site and also conduct brief clinical assessments to see if emergency telemedicine visits are needed since there are concerns that people may not be going to the hospital or their doctor’s offices even when they are sick out of fear of COVID. 

Teams are also assessing for social needs such as food availability, financial assistance, temporary housing needs and are connecting vulnerable populations with resources they need, including education about the disease to help them stay safe. 

By using this proactive approach, health officials can identify those at greatest risk of ending up in the hospital or ICU and try to prevent that from happening through early outreach testing and management. We know our vulnerable populations at greatest risk from COVID-19 and this kind of approach is being put in place to prevent negative outcomes as well as prevent the overwhelming EDs and hospitals.  

On a community level, Socially Determined took the following key factors into account when determining COVID-19 susceptibility on a community level:

- Age Distribution

- Community Disease Burden

- Population Density

- Economic Stress

- Exposure Potential

- Infrastructure

 On the individual level, Socially Determined took the following key factors into account:

- Age

- Chronic Disease History

- Social Determinants of Health Risk Data

Testing and Manage in Place Teams are working in communities right now and we can provide you with visuals or access to team members in action in vulnerable areas. We can also connect you with Dr. Mani, experts from Socially Determined as well as public health officials who are using the information to guide their efforts. We can show you what is being done and the impact it is having to reduce the spread of COVID-19 and reducing the burden on healthcare systems throughout the state.

 This is a unique approach to battling COVID-19 that could be adopted nationally. 

 




Filters close

Showing results

110 of 5419
Released: 15-Apr-2021 4:10 PM EDT
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
Perelman School of Medicine at the University of Pennsylvania

New findings from Penn suggest that people who have recovered from COVID-19 may only need a single mRNA vaccine dose. However, those who did not have COVID-19 did not have a full immune response until after a second vaccine dose, reinforcing the importance of completing the two recommended doses.

Released: 15-Apr-2021 4:00 PM EDT
June 2021 Issue of AJPH Comprises the Effects of COVID-19 on Drug Overdoses, E-cigarette Use, and Public Health Measures and Strategies
American Public Health Association (APHA)

June 2021 AJPH Issue highlights COVID-19 concerns in relation to fatal drug overdoses, drops in youth e-cigarette use, importance of public health measures, and strategies to protect correctional staff.

Newswise: 262150_web.jpg
Released: 15-Apr-2021 3:20 PM EDT
COVID-19 reduces access to opioid dependency treatment for new patients
Princeton University

COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.

Newswise: UGA to Establish National NIH-funded Center to Fight Flu
Released: 15-Apr-2021 2:45 PM EDT
UGA to Establish National NIH-funded Center to Fight Flu
University of Georgia

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research (CIDER). The contract will provide $1 million in first-year funding and is expected to be supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, for seven years and up to approximately $92 million.

Released: 15-Apr-2021 2:15 PM EDT
Meatpacking plants increased COVID-19 cases in US counties
University of California, Davis

An estimated 334,000 COVID-19 cases are attributable to meatpacking plants, resulting in $11.2 billion in economic damage, according to a new study led by a researcher at the University of California, Davis.

Newswise: 262052_web.jpg
Released: 15-Apr-2021 1:55 PM EDT
How to build a city that prioritizes public health
Colorado State University

Most people by now have memorized the public health guidelines meant to help minimize transmission of COVID-19: wash your hands, wear a mask, keep six feet apart from others. That part is easy.

Released: 15-Apr-2021 1:45 PM EDT
Wake Forest School of Medicine Begins Study to Test New Mask for Healthcare Workers
Wake Forest Baptist Health

Open Standard Industries, Inc. (OSI), manufacturer of the OSR-M1 non-valved reusable elastomeric face mask, is pleased to formally announce the launch of its first Institutional Review Board (IRB)-approved user feasibility study. The trial is being led by the departments of Biomedical Engineering and Infectious Diseases at Wake Forest School of Medicine, part of Wake Forest Baptist Health. Recruitment in the study is underway, and enrollment is expected to be completed by May 28, 2021.

Newswise: Major clinical trial to test Pfizer-BioNTech COVID-19 vaccine opens for enrollment at UTHealth in Houston
Released: 15-Apr-2021 1:45 PM EDT
Major clinical trial to test Pfizer-BioNTech COVID-19 vaccine opens for enrollment at UTHealth in Houston
University of Texas Health Science Center at Houston

A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).

Released: 15-Apr-2021 1:15 PM EDT
For veterans, a hidden side effect of COVID: Feelings of personal growth
Yale University

The U.S. military veteran population is known to have abnormally high rates of suicide, so health officials have been concerned that the COVID-19 pandemic might elevate risk of psychiatric disorders, particularly among those suffering from post-traumatic stress and related disorders.

Newswise: 262026_web.jpg
Released: 15-Apr-2021 12:55 PM EDT
Significant spread of all coronavirus variants tracked in Houston area
Elsevier

In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines.


Showing results

110 of 5419

close
1.26668